Venture Life Group plc (AIM:VLG)
London · Delayed Price · Currency is GBP · Price in GBX 66.67
-0.34 (-0.50%)
Apr 16, 2026, 4:28 PM GMT
Venture Life Group Revenue
In the year 2025, Venture Life Group had annual revenue of 35.17M GBP with 32.24% growth. Venture Life Group had revenue of 19.78M in the half year ending December 31, 2025.
Revenue
35.17M
Revenue Growth
+264.01%
P/S Ratio
2.32
Revenue / Employee
817.84K
Employees
43
Market Cap
81.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.17M | 8.57M | 32.24% |
| Dec 31, 2024 | 26.59M | 4.23M | 18.90% |
| Dec 31, 2023 | 22.37M | -21.62M | -49.15% |
| Dec 31, 2022 | 43.98M | 11.22M | 34.24% |
| Dec 31, 2021 | 32.76M | 2.69M | 8.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Haleon | 11.03B |
| Hikma Pharmaceuticals | 2.49B |
| HUTCHMED (China) | 407.54M |
| ECO Animal Health Group | 85.81M |
| Animalcare Group | 81.07M |
| Allergy Therapeutics | 57.29M |
| Shield Therapeutics | 36.93M |
| Provexis | 871.27K |